Role of angiotensin ii in glomerular injury: Lessons from experimental and clinical studies

Kidney and Blood Pressure Research

Volumn 19, Issue 5, 1996, Pages 254-262

  Hilgers, Karl F ^a   Mann, Johannes F E ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

Angiotensin; Chronic renal failure; Generation; Glomerulosclerosis; Glomerulus; Growth factors

Indexed keywords

ANGIOTENSIN; ANGIOTENSINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; OCTAPEPTIDE; RENIN;

BLOOD PRESSURE; CELL GROWTH; CELL INFILTRATION; CHRONIC KIDNEY FAILURE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEINURIA; RENIN RELEASE; REVIEW;

EID: 0029855742     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000174085     Document Type: Article

References (112)

1. Wolf G, Ncilson EG: Angiotensin II as a renal growth factor, .J Am Soc Nephrol 1993:3:1531-1540.
2. Schclling P, fischer II, Gantcn D: Angiotensin anti cell growth: A link to cardiovascular hypertrophy? J Hypertcns 1991:9:3-15.
3. Urata II, Kinishita A, Perez DM, Misono KS, Bumpus FM, Graham RM, Husain A: Cloning of the gene ami cDNA for human heart chy-mase, .J Biol Ghcm 1991;266:17173-17179.
4. Dzau VJ: Multiple pathways of angiotensin production in the blood vessel wall: Evidence, possibilities and hypotheses, J Hypertcns 1989: 7:933-939.
5. I larding JW, Wright JW, Swanson GN, I lanes-wortli JM, Krebs LT: A'1'4 receptors: Specificity and distribution, Kidney Int 1994:46:1510-1512.
6. Gomez RA, Gloor JM: Expression of the renin-angiotensin system in the kidney; in Laragh Jl i, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, New York, Raven Press, 1995, pp 1637-1652.
7. Hackenthal E, Paul M, Ganten D, Taugner R: Morphology, physiology, and molecular biology of renin secretion, Physiol Rev 1990:70: 1067-1116.
8. Gomez RA, Chevalier RL, Everett AD, Elwood JP, Peach MJ, Lynch KR, Carey RM: Recruitment of renin gene-expressing cells in adult rat kidneys, Am J Physiol 1990:259:F660-F665.
9. Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, Wilfong N, Peach MJ, Carey RM: Renin and angiotensinogen gene expression and intrarcnal renin distribution during ACE inhibition, Am .1 Physiol 1988:254: F900-F906.
10. Terada Y, Tomita K, Nonoguehi H, Marumo F: PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney, Kidney Int 1993:43:1251-1259.
11. Kim HS, Kregc JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CS, Jenette JC, Coffman TM, Maeda N, Smilhies O: Genetic control of blood pressure and the angiotensinogen locus, Proc Natl Acad Sci USA 1995;92:2735-2739.
12. Song L, Troyanovskaya M, VVilk E, Wilk S, Healy DP: Rat kidney glutamyl aminopcptida.se (aminopeptidase A): Molecular identity and cellular localization, Am .1 Physiol 1994;207: F546-F557.
13. Assmann K.IM, van Son JPHF, Dijkman HBPM, Kocne RA: A ncphritogcnic rat monoclonal antibody to mouse aminopeptidase A; Induction of massive albuminuria after a single intravenous injection, J Exp Med 1992:175: 623-635.
14. Schcrberich JE, Matthcss A, Remelius W, Sehocppc W: Aminopeptidase A (= angiotensi-nase A) in human progressive renal disease, Miner Electrolyte Metab 1992; 18:97-100.
15. Wolf G, Thaiss F, Miillcr E, Disser M, Pooth R, Zahner G, Stahl RA: Glomerular mRNA expression of angiotensinasc A after renal ablation, Exp Nephrol 1995:3:240-248.
16. Mai M, Hilgers KF, Wagner J, Mann JFE, Geiger II: Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney, Hypertension 1995:25:674-678.
17. Scikaly MG, Arant BS Jr, Scney FD Jr: Endogenous angiotensin concentrations in specific in-trarenal fluid compartments of the rat, J Clin Invest 1990:86:1352-1357.
18. Ativeh BA, Arant BS Jr, Ilenrich WL, Scikaly MG: In vitro production of angiotensin II by isolated glomeruli, Am J Physiol 1995:268: F266-F272.
19. Braam B, Mitchell KD, Fox L, Navar LG: Proximal tubular secretion of angiotensin II in rats, Am J Physiol 1993:264:1-891 F898.
20. Wilcox CS, Dzau VJ: Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph, J Am Soc Nephrol 1992;2:1241-1250.
21. Siragy HM, Howell NL, Ragsdale NV, Carey RM: Renal interstitial fluid angiotensin: Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition, Hypertension 1995:25:1021-1024.
22. Admiraal PJJ, Danser AH, Jong MS, Picter-man H, Derkx FHM, Schalekamp MADH: Regional angiotensin II production in essential hypertension and renal artery stenosis, Hypertension 1993;21:173-184.
23. Fisher ND, Allan DR, Gaboury CI, Hollenberg NK: Intrarenal angiotensin II formation in humans: Evidence from renin inhibition, Hypertension 1995:25:935-939.
24. Gomez RA: Angiotensin receptors: Relevance in development and disease states, Exp Nephrol 1994:2:259-268.
25. Inagami T, Guo DF, Kitami Y: Molecular biology of angiotensin II receptors: An overview, J Hypertcns 1994; 12(suppl 1):83-94.
26. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Caritii D.I, Lee R.I, Wexler RR, Saye JA, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists, Pharmacol Rev 1993:45:205-251.
27. dc Gasparo M, Levens NR: Pharmacology of angiotensin II receptors in the kidney, Kidney Int 1994:46:1486-1491.
28. Bhal GJ, Thekkunikara TJ, Thomas WG, Conrad KM, Baker KM: Angiotensin II stimulates sis-inducing factor-like DNA binding activity: Evidence that the AT IA receptor activates transcription factors-Stat91 and/or a related protein. J Biol Chem 1994:269:31443-31449.
29. Marrero MB, Schlcffer B, Paxton WG, Hecrdt I, Berk BC, Dclafontaine P, Bernstein KE: Direct stimulation of the Jak/STAT pathway by the angiotensin II ATI receptor, Nature 1995:375: 247-250.
30. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuehi M, Pratt RE, Dzau VJ: The angiotensin II type 2 (AT2) receptor antagonizes the growth effect of the ATI receptor: Gain-of-function study using gene transfer, Proc Natl Acad Sei USA 1995:92: 10663-10667.
31. Yamada T, Horiuehi M, Dzau VJ: Angiotensin II type 2 receptor mediates programmed cell death, Proc Natl Acad Sei USA 1996:93:156-160.
32. Hein L, Barsli GS, Pratt RE, Dzau VJ, Kobilka BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type 2 receptor gene in mice, Nature 1995:377:744-747.
33. Icliiki T, Iaboskv PA, Shiota C, Okuyama S, Iniagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan Bl VI, Inagami T: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type 2 receptor, Nature 1995:377: 748-750.
34. Dulin NO, Ernsberger P, Sueiu DJ, Douglas JG: Rabbit renal epithelial angiotensin II receptors, Am J Physiol 1994:267:F776-F782.
35. Tufro-McReddie A, Harrison JK, Everett AD, Gomez RA: Ontogeny of type I angiotensin II receptor gene expression in the rat, .J Clin Invest 1993:91:530-537.
36. Sochi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M: Distribution of angiotensin II receptor subtypes in rat and human kidney, Am J Physiol 1992;262:F236-F240.
37. Wilcox CS, Welch WJ, Snellen H: Thromboxane mediates renal hemodynamic response to infused angiotensin II, Kidney Int 1991:40: 1090-1097.
38. Johns EJ: Role of angiotensin 11 and the sympathetic nervous system in the control of renal function, J Hypertcns 1989:7:695-701.
39. Yuan Bll, Robinette JB, Conger JD: Effect of angiotensin II and norepinephrine on isolated rat afferent and efferent arterioles, Am J Physiol 1990;258:F741-F750.
40. Remuzzi A, Puntoricri S, Battagl ia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat, .J Clin Invest 1990:85:541-549.
41. Yosliida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I: Effect of antihypertensive drugs on glomerular morphology, Kidney Int 1989:36: 626-635.
42. Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM: Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril, Am .1 Med 1984:76(suppl):29-37.
43. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992:90:766-771.
44. Mayer G, Lafayette RA, Oliver J, Deoil WM, Myers BD, Meyer TW: Effects of angiotensin II receptor blockade on remnant glomerular permselectivity, Kidney Int 1993;43:346-353.
45. Chanscl D, Czckalski S, Pham P, Ardaillou R: Characterization of angiotensin II receptor sub-types in human glomeruli and mesangial cells, Am J Physiol 1996:262:F432-F441.
46. Barnett RL, Ruffini L, Ramsammy L, Pasman-tier R, Friedlaender MM, Nord EP: Angiotensin-mediated phosphatidylcholine hydrolysis and protein kinase C activation in mesangial cells, Am J Physiol 1993;265:C1100-C1108.
47. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986:77:1993-2000.
48. Yosliida Y, Fogo A, Ichikawa I: Glomerular hémodynamie change versus hypertrophy in experimental glomerular sclerosis, Kidney hit 1989:35:654-660.
49. Pupilli C, Chevalier RL, Carey RM, Gomez RA: Distribution and content of renin and renin mRNA in remnant kidney of adult rat, Am J Physiol 1992:263:F731-F738.
50. Miller PL, Rennke HG, Meyer TW: Hypertension and progressive glomerular injury caused by focal glomerular ischemia, Am .1 Physiol 1990:259: F239-F245.
51. Terzi F, Beauftls II, Laouari D, Burtin M, Kleitiknecht C: Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model, Kidney Int 1992; 42:354-363.
52. Griffin KA, Picket! M, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury, J Am Soc Nephrol 1994:4:2023-2031.
53. Bidani AK, Mitchell KD, Schwartz MM, Navar LG, Lewis EJ: Absence of glomerular injury of nephron loss in a normotensive rat remnant kidney model, Kidney Int 1990:38:28-38.
54. Itoli H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin 11, J Clin Invest 1993; 91:2268-2274.
55. StoulTer GA, Owens GK: Angiotensin ll-in-duced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta, Circ Res 1992:70: 820-828.
56. Dubcy RK, Roy A, Ovcrbcck HW: Culture of renal arteriolar smooth muscle cells: Mitogenic response to angiotensin II, Circ Res 1992:71: 1143-1152.
57. Daemon MJ, Lombardi DM, Bosnian FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall, Cire Res 1991:68:450-456.
58. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Flocgc J, Schwartz SM: Renal injur from angiotensin ll-mediated hypertension, Hypertension 1992; 19:464-474.
59. Turla MB, Thompson MM, Corjay MIL Owens GK: Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured nit aortic smooth muscle cells: Evidence for selective increases in smooth muscle isoactin expression, Cite Res 1991:68:288-299.
60. Hershey JC, Hautmann M, Thompson MM, Rothblum LI, Ilaystcad TAJ, Owens GK: Angiotensin ll-induccd hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor, J Biol Chem 1995:270:25096-25101
61. Huwiler A, Stabcl S, Fabbro D, Pfeilschifter J: Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: Comparison of hypertrophic and hyperplastic agonists, Bioehem J 1995:305:777-784.
62. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE: Angiotensin II stimulates human fetal mesangial cell proliferation and fibro-ncctin biosynthesis by binding to ATI receptors, Kidney Int 1994;45:177-184.
63. Anderson PW, Do YS, Hsueh VA: Angiotensin II causes mesangial cell hypertrophy, Hypertension 1993:21:29-35.
64. Schulze-Lohoff E, Kohler M, Fees H, Rcindl N, Sterzcl RB: Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in culture rat glomerular mesangial cells, J Hypcrtcns 1993:11:127-134.
65. Wolthuis A, Bocs A, Rodemann HP, Grond J: Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells, Kidney Int 1992:41:124-131.
66. Mai M, Geiger IL Hilgers KF, Vcelken R, Mann JFE, üümnirich J, Lufl FC: Early interstitial changes in hypertension-induced renal injury, Hypertension 1993:22:754-765.
67. Veniant M, Hettdes D, Clozel JP, Bruneval P, Menard J: Calcium blockade versus ACE inhibition in clipped and undipped kidneys of 2K- 1C rats, Kidney Int 1994:46:421-429.
68. Arai M, Wada A, Isaka Y, Akagi Y, Sttgiura T, Miyazaki M, Moriyama T, Kaneda Y, Naruse K, Naruse M, Orita Y, Ando A, Kamada T, Ueda N, Imai E: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic changes of the mesangial cells and glomerular sclerosis, Bioehem Bio-phys Res Commun 1995:206:525-532.
69. Ketteler M, Noble NA, Border WA: Transforming growth factor beta and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 1995: 57:279-295.
70. Gomez RA, Norling LL, Wilfong N, Isakson P, Lynch KR, Flock R, Quesenberry P: Leukocytes synthesize angiotensinogen, Hypertension 1993:21:471-475.
71. Kitanoza T, Padgett RC, Armstrong ML, Tompkins PK, Heistad DD: Evidence that angiotensin II is present in human monocytes, Circulation 1995:91:1129-1134.
72. Iwai N, Inagami T, Ohmichi N, Kinoshita M: Renin is expressed in rat macrophage/mono-cyte cells, Hypertension 1996:27:399-403.
73. Hahn AW, Jonas U, Bidder FR, Rcsnik TJ: Activation of human peripheral monocytes by angiotensin II, FEBS Lett 1994:347:178-180.
74. Brasier AR, Il J, Copland A: Transcription factors modulating angiotensinogen gene expression in hépatocytes, Kidney Int 1994:46:1564-1566.
75. Lazarus DS, Aschoff J, Fanburg BL, Lanzillo JJ: Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines, Bio-chim Biophys Acta 1994; 1226:12-18.
76. Moriyama T, Fujibayashi M, Fujiwara Y, Kanc-ko T, Xia C, Imai E, Kamada T, Ando A, Ueda N: Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells, J Am Soc Nephrol 1995:6:95-101.
77. Mené P, Fais S, Cinotti GA, Pugliese F, Lutt-mann W, Thierauch Kll: Regulation of U-937 monocyte adhesion to cultured human mesangial cells by cytokines and vasoactive agents, Nephrol Dial Transplant 1995:10:481-489.
78. Eng E, Veniant M, Flocgc J, Fingerle J, Alpers CE, Menard J, Clozel JP, Johnson R.I: Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldhlatt hypertension, AmJ Hypertens 1994:7:177-185.
79. Clozel M, Kuhn II, Hefti F, Baumgartner HR: Endothelial dysfunction and subcndothelial monocyte macrophages in hypertension, Effect of angiotensin converting enzyme inhibition, Hypertension 1991;18:132-141.
80. Linz VV, Wiemer G, Goltlke P, Linger T, Schol-kens BA: Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors, Pharmacol Rev 1996:47: 25-49.
81. Ichikawa I: Will angiotensin II receptor antagonists be rcnoprotective in humans? Kidney Int 1996:50:684-692.
82. Flricik DE, Dunn M.I: Angiotensin-converting enzyme inhibitor-induced renal filurc: Causes, consequences, and diagnostic uses, J Am Soc Nephrol 1990;1:845-858.
83. Jackson B, Franze L, Sumithran E, Johnston Cl: Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat, J Lab Clin Med 1990:115:21-27.
84. Nochy IJ, Barresü B, Camilleri J-P, Baricty J, Corvol P, Menard J: Abnormalities of renin-containing cells in human glomerular and vascular renal diseases, Kidney Int 1983:23:375-379.
85. Steen VD, Costatino JP, Shapiro AP, Medsger TA: Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme inhibitors, Ann Intern Med 1990:113:352-357.
86. Kim S, Ohta K, Ilamaguchi A, Omura T, Yu-kimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F, Iwao H: Contribution of renal angiotensin Il type I receptor to gene expressions in hypertension-induced renal injury, Kidney Int 1994:46:1346-1358.
87. Everett AD, Scott J, Wilfong N, Marino B, Rosenkranz RP, Inagami T, Gomez RA: Renin and angiotensinogen expression during the evolution of diabetes, Hypertension 1992:19:70-78.
88. Correa-Rotter R, Hostettcr TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabetes mellitus, Kidney Int 1992;41:796-804.
89. Anderson S, Jung FF, Ingclfingcr JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations, Am .J Physiol 1993:265:1477-1486.
90. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat, Kidney Int 1989:36:526-536.
91. Sassy-Prigent C, lleudcs D, Jouquey S, Auber-val D, Beiair ME Michel O, Hamon G, Bariety J, Bruneval P: Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats: Protective effects of ACE inhibition, Lab Invest 1995:73:64-71.
92. Pars ing HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy, BMJ 1988;297:1086-1091.
93. Björck S, Mulec H, Johnsen SA, Norden G, Au-rell M: Renal protective effect of enalapril in diabetic nephropathy, BMJ 1992:304:339-343.
94. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy, N Engl .J Med 1993:329:1456-1462.
95. Schmidt S, Schone N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group, Kidney Int 1995:47:1176-1181.
96. Dudley CR, Kcavney B, Stratton IM, Turner RC, Ratcliffc PJ: U.K, Prospective Diabetes Study, XV Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM, Kidney Int 1995:48:1907-1911.
97. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Ilamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus, Kidney Int 1996;50:657-664.
98. Lacourcicrc Y, Nadeau A, Poirier L, Tancrcdc G: Captopril or conventional therapy in hypertensive type II diabetics: Three-year analysis, Hypertension 1993:21:786-794.
99. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria, BMJ 1991;302:210-216.
100. Wagner J, Drab M, Gehlen F, Langhcinrich M, Volk S, Ganten D, Ritz F.: PCR analysis of human renal biopsies: Renin gene regulation in glomerulonephritis, Kidney Int 1994:46: 1542-1545.
101. Yoshida II, Mitarai T, Kawamura T, Kitayima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Ku-bo H, Ichikawa I, Sakai O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy, J Clin Invest 1995;96:2162-2169.
102. van Essen GG, Rcnsma PL, De Zeeuw D, Slui-ter WJ, Scheffer H, Apperloo AJ, De Jong PE: Association between angiotensin-converting enzyme gene polymorphism and failure of re-noprotective therapy, Lancet 1996:347:94-95.
103. Lachurié M-L, Azizi M, Guyene T-T, Alhcnc-Gclas F, Menard J: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects, Circulation 1995:91:2933-2942.
104. Ueda S, Elliott HE, Morton JJ, Connell JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype for angiotensin-converting enzyme, Hypertension 1995:25:1266-1269.
105. Bedogna V Valvo E, Casagrande P, Braggio P, Fontanarosa C, Dal Santo F, Alberti D, Mas-chioG: Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function, Kidney Int 1990: 38:101-107.
106. Praga M, Ilemàndez E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria, Am J Kidney Dis 1992:20:240-248.
107. Gansevoort RT, De Zeeuw D, De Jong PE: Is the ant proteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994:45:861-867.
108. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klalir S, Massry SG, Scifter JL: Blood pressure control, proteinuria, and the progression of renal disease, Ann Intern Med 1995:123:754-762.
109. Mann JFE, Ritz E: Preservation of kidney function by use of converting enzyme inhibitors for control of hypertension, Lancet 1987: vol ii:622.
110. Hannedouchc T, Landais P, Goldfàrb B, El Esper N, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suc S-M, Grünfcld J-P: Randomised controlled trial of cnalapril and beta-blockers in non-diabetic chronic renal failure, BMJ 1996:309:833-837.
111. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolcsc M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency, The angiotensin-Converting Enzyme Inhibition iii Progressive Renal Insufficiency Study Group, N Engl J Med 1996:334:939-945.
112. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure, Kidney Int 1992:42:46-55.